We are live on
!
Find out more
AP
Andera Partners Portfolio holdings
AUM
$177M
This Fund
S&P 500
This Quarter
Est. Return
+2.77%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
–
Cap. Flow
+$182M
Cap. Flow
% of AUM
102.98%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KMTS
Kestra Medical Technologies
KMTS
|
+$65.4M |
| 2 |
Mineralys Therapeutics
MLYS
|
+$63.8M |
| 3 |
EVMN
Evommune Inc
EVMN
|
+$35.6M |
| 4 |
ABVX
Abivax
ABVX
|
+$8.52M |
| 5 |
IVA
Inventiva
IVA
|
+$8.45M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CTC
AGC
CPL
ACM
WFL
PFP
ES
ACM
Andera Partners's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Andera Partners, which disclosed 5 positions worth $177M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Kestra Medical Technologies: 2,540,106 shares worth $67.4M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Andera Partners's largest Q4 2025 buy was Kestra Medical Technologies: 2,540,106 shares worth $67.4M.
- Andera Partners's ten largest holdings make up 100% of its $177M portfolio in Q4 2025.
- Andera Partners disclosed 5 positions in Q4 2025, its first 13F filing on record.
Based on Andera Partners's 13F filing for Q4 2025, filed 17 Feb 2026.